Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Dosanjh, Laura E.a | Brown, Marishka K.a | Rao, Gautama | Link, Christopher D.c | Luo, Yuana; b; *
Affiliations: [a] Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, USA | [b] Center for Integrative Medicine, School of Medicine, University of Maryland, Baltimore, MD, USA | [c] Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80309, USA
Correspondence: [*] Corresponding author: Dr. Yuan Luo, Pharmacy Hall, University of Maryland, 20 N Pine Street, Room 500, Baltimore, MD 21201, USA. Tel.: +1 410 706 6639; Fax: +1 410 706 0346; E-mail: [email protected].
Abstract: Alzheimer's disease (AD) is rapidly reaching epidemic proportions in the United States, currently affecting more than 5 million individuals and predicted to affect 14 million by 2050. Despite a general consensus that the amyloid-β (Aβ) protein plays a significant role in disease progression, the underlying pathology of the disease is not entirely clear. Caenorhabditis elegans is a simple organism that has been used as a model for basic mechanistic studies on the underlying pathological processes involved in AD. Previous studies from our labs demonstrated that transgenic C. elegans with muscle specific expression of human Aβ undergo rapid paralysis, and worms with neuronal expression of Aβ show deficits in chemotaxis to volatile chemicals. In this study, we evaluate the effect of neuron specific expression of Aβ on multiple neuronally controlled behaviors in a transgenic C. elegans. These worms demonstrate deficits in odorant preference associative learning behavior, and the serotonin-controlled behaviors experience-dependent learning and egg laying. These newly identified learning-deficit behavioral phenotypes in the neuronal Aβ C. elegans suggest that the model may be used to elucidate underlying pathological events related to development of AD and for pharmaceutical intervention.
Keywords: Amyloid toxicity, C. elegans, genotyping, neurological behavioral
DOI: 10.3233/JAD-2010-1267
Journal: Journal of Alzheimer's Disease, vol. 19, no. 2, pp. 681-690, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]